Atlas Trials

Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.

Clinical trial NCT01148979 · COMPLETED

Trial details

NCT number
NCT01148979
Sponsor
Mclean Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2010-09-01
Primary completion
2014-09-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.